http://ift.tt/eA8V8J A new class of drugs for blood cancers such as leukemia and multiple myeloma is showing promise. But it is hobbled by a problem that also plagues other cancer drugs: targeted cells can develop resistance. Now scientists have found that insights into a rare genetic disease known as NGLY1 deficiency could help scientists understand how that resistance works -- and potentially how drugs can outsmart it.
from http://ift.tt/2ixJ9HU
via IFTTT
#1 Drug Treatment Center. Expert Medical Detox· Privacy & Safety · Caring & Compassionate CALL NOW 844-463-1889
GET HELP NOW
Subscribe to:
Post Comments (Atom)
Children whose mothers use marijuana are more likely to try it at younger age
When mothers use marijuana during the first 12 years of their child's life, their cannabis-using children are more likely to start at an...
-
http://ift.tt/eA8V8J Researchers have shown that virtual particles known as skyrmions, discovered just a few years ago, hold promise as a ne...
-
http://ift.tt/eA8V8J Researchers link autism spectrum disorders to defects in a nuclear receptor inside the brain. from http://ift.tt/2HwG...
-
At a time when drug overdoses are becoming more prevalent and lethal, a new report provides a snapshot of regional illicit drug use and, for...
No comments:
Post a Comment